Proprio Spine Measurement Tool

by palligoelme@gmail.com | Jun 17, 2025 | Clinical Trials

​ Conditions: Intervertebral Disc Degeneration; Intervertebral Disc Displacement; Spinal Curvatures; Spinal Osteochondrosis; Spinal Osteophytosis; Spinal Stenosis; Spondylitis; Spondylosis Interventions: Device: Intraoperative spinal measurement system Sponsors: Duke...

A Safety and Tolerability Clinical Trial of PST-611 in Dry Age-related Macular Degeneration

by palligoelme@gmail.com | Jun 17, 2025 | Clinical Trials

​ Conditions: Dry Age Related Macular Degeneration Interventions: Biological: PST-611 Sponsors: Eyevensys Not yet recruiting Conditions: Dry Age Related Macular Degeneration Interventions: Biological: PST-611 Sponsors: Eyevensys Not yet...

Piloting and Evaluation of a Group Intervention for People With Psychosis Designed to Boost Access and Usage of ICT

by palligoelme@gmail.com | Jun 17, 2025 | Clinical Trials

​ Conditions: Serious Mental Illness Interventions: Behavioral: Group ICT Intervention Sponsors: McMaster University; St. Joseph’s Healthcare Hamilton Not yet recruiting Conditions: Serious Mental Illness Interventions: Behavioral: Group ICT Intervention...

Reliability and Validity Study of the Turkish Version of the Parkinson’s Disease Dyskinesia Scale (PDYS-26)

by palligoelme@gmail.com | Jun 17, 2025 | Clinical Trials

​ Conditions: Idiopathic Parkinson Disease; Dyskinesias; Quality of Life Interventions: Other: Turkish version of the Parkinson’s Disease Dyskinesia Scale (PDYS-26) Sponsors: Izmir Bakircay University Recruiting Conditions: Idiopathic Parkinson Disease;...

A Phase III Clinical Study of Cadonilimab Plus SOX as Perioperative Treatment for Patients With Resectable G/GEJ Adenocarcinoma

by palligoelme@gmail.com | Jun 16, 2025 | Clinical Trials

​ Conditions: Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma Interventions: Drug: Cadonilimab; Drug: SOX chemotherapy Sponsors: Akeso Not yet recruiting Conditions: Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma Interventions: Drug:...

A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

by palligoelme@gmail.com | Jun 16, 2025 | Clinical Trials

​ Conditions: Colorectal Cancer Interventions: Drug: Telisotuzumab Adizutecan; Drug: Standard of Care Sponsors: AbbVie Not yet recruiting Conditions: Colorectal Cancer Interventions: Drug: Telisotuzumab Adizutecan; Drug: Standard of Care Sponsors: AbbVie Not yet...